Home / Inspections / 1181518

FDA Inspection 1181518 — Emory University Hospital Midtown- Center for Transfusion & Cellular Therapies

Emory University Hospital Midtown- Center for Transfusion & Cellular Therapies — FEI 1071491

The FDA completed an inspection of Emory University Hospital Midtown- Center for Transfusion & Cellular Therapies on September 14, 2022 in Atlanta, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 14, 2022
Fiscal Year
2022
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Atlanta, GA (United States)

Facility

Other inspections at this facility

  • 1251574 (NAI Tue Sep 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1074982 (NAI Fri Nov 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1010331 (NAI Fri Apr 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 923099 (VAI Mon Apr 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 816012 (VAI Fri Feb 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources